Reportlinker

http://www.reportlinker.com

Reportlinker Adds Competitor Analysis: VEGF and VEGF-R Agonists and Antagonists

Friday 16th of October 2009 10:01

Index

    --  2008 Sales of VEGF/R Antagonists
    --  VEGF-R Agonists
        --  Cardiovascular Applications
        --  Neurological Applications
    --  VEGF and VEGF-R Antagonists in Ophthalmology
    --  VEGF and VEGF-R Antagonists in Oncology
        --  Avastin Pipeline
        --  Biologics as VEGF and VEGF-R Antagonists
        --  Small Molecules as VEGF RTK Inhibitors
        --  Sutent Pipeline
        --  Nexavar Pipeline
        --  Selective VEGF RTK Inhibitors
        --  Dual Target VEGF RTK Inhibitors
        --  Triple Target VEGF RTK Inhibitors
        --  Multi-Target VEGF RTK Inhibitors
        --  Overview on RTK Inhibion Profiles of VEGF-R Inhibitors
    --  Corporate VEGF and VEGF-R Agonists and Antagonists

    --  About La Merie

Corporate VEGF/R Agonist and Antagonist R&D Pipelines

    --  Accelera
    --  ACT Biotech
    --  Advenchen Laboratories
    --  Affitech
    --  Allergan
    --  Allostera Pharma
    --  Alnylam Pharmaceuticals
    --  Amgen
    --  Ark Therapeutics
    --  AstraZeneca
    --  Attenuon
    --  Aveo Pharmaceuticals
    --  Bayer Schering-Pharma
    --  Bio-Sidus
    --  Boehringer Ingelheim
    --  Bristol-Myers Squibb (BMS)
    --  Cephalon
    --  Chugai
    --  Circadian
    --  CSL
    --  Cyclacell Pharmaceuticals
    --  DxS
    --  Edwards Lifesciences
    --  Eisai
    --  Eli Lilly
    --  Epitomics
    --  Ethycal Oncology Sciences (EOS)
    --  Exelixis
    --  Eyetech
    --  Genentech
    --  GlaxoSmithKline (GSK)
    --  Jubilant Innovation
    --  Kringle Pharmaceuticals
    --  Methylgen
    --  Millennium
    --  Molecular Partner
    --  Nanogen Biopharmaceuticals
    --  Neovacs
    --  NeuroNova
    --  Neurotech
    --  Novartis
    --  Onyx Pharmaceuticals
    --  Opko
    --  OSI Pharmaceuticals
    --  Oxford BioMedica
    --  Pepscan Systems
    --  Pfizer
    --  Pieris
    --  PTC Therapeutics
    --  Regeneron Pharmaceuticals
    --  Roche
    --  Sangamo Biosciences
    --  Sanofi-aventis
    --  Schering
    --  SibTech
    --  Sirna Therapeutics
    --  Sopherion Therapeutics
    --  Symphony Evolution
    --  Takeda Pharmaceutical
    --  Targa Therapeutics
    --  Tekmira
    --  Telik
    --  Tigris Pharmaceuticals
    --  Toolgen
    --  Trophogen
    --  VasGene

    --  ZymoGenetics

To order this report:

Reportlinker Adds Competitor Analysis: VEGF and VEGF-R Agonists and Antagonists

http://www.reportlinker.com/p0154668/Reportlinker-Adds-Competitor-Analysis-VEGF-and-VEGF-R-Agonists-and-Antagonists.html

More market research reports here!

    CONTACT:
    Nicolas Bombourg
    Reportlinker
    Email: nbo@reportlinker.com
    US: (805)652-2626
    Intl: +1 805-652-2626

SOURCE Reportlinker

Source PR Newswire


www.prnewswire.co.uk

Browse news from 2009

Download PDF